Infection and Drug Resistance, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to the critical fields of infectious diseases and pharmacology. Since its establishment in 2008, this journal has emerged as a vital resource for researchers, professionals, and students alike, offering thorough insights into the mechanisms of drug resistance and the effectiveness of various therapeutic interventions. With an impressive 2023 impact factor placing it in the Q2 category across multiple relevant disciplines, including Infectious Diseases and Pharmacology, it serves as a significant platform for high-quality research dissemination. Infection and Drug Resistance aims to foster a deeper understanding of the evolving challenges in managing infectious diseases and enhancing drug efficacy, contributing to the global discourse on public health. The journal's commitment to open access ensures that vital knowledge is readily available to promote broader scholarly engagement and innovation.

Tropical Biomedicine, published by the Malaysian Society of Parasitology and Tropical Medicine, is an influential journal dedicated to the field of infectious diseases and parasitology. Since its inception in 2005, the journal has aimed to advance scientific knowledge and foster research in tropical health, providing a vital platform for disseminating high-quality research findings, case studies, and reviews. With a Q3 ranking in Infectious Diseases and a Q4 in Parasitology for 2023, the journal plays an essential role in addressing the challenges faced in these fields, particularly in tropical and subtropical regions. Although currently not open access, its contributions are pivotal for researchers, healthcare professionals, and students dedicated to combating diseases prevalent in diverse ecological environments. By focusing on relevant topics and innovative approaches, Tropical Biomedicine seeks to enlighten and inspire the ongoing fight against tropical diseases, ultimately improving public health outcomes.

Tropical Medicine and Infectious Disease, published by MDPI, is a leading peer-reviewed journal dedicated to advancing the field of tropical medicine and infectious diseases. With an open access model established since 2016, this journal fosters a collaborative environment for researchers, professionals, and students from around the world to disseminate cutting-edge findings and innovative approaches to public health challenges, particularly in tropical regions. The journal has earned recognition, achieving a Q2 quartile ranking in notable fields including Immunology and Microbiology, Infectious Diseases, and Public Health, Environmental, and Occupational Health in 2023, indicative of its influence and relevance in the scientific community. With a focus on high-quality research, Tropical Medicine and Infectious Disease aims to bridge the gap between basic science and clinical application, providing invaluable insights critical for combating infectious diseases and improving health outcomes in vulnerable populations. The journal’s accessibility and substantial indexing in major databases further solidify its importance as a key platform for impactful research in this essential field.

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases is a leading peer-reviewed journal dedicated to advancing the field of infectious diseases, particularly focusing on tuberculosis and other mycobacterial infections. Published by ELSEVIER in the United Kingdom with an impressive open access model since 2015, this journal aims to provide a platform for the dissemination of high-quality research, clinical findings, and innovative methodologies in the management of mycobacterial diseases. With a commendable impact, the journal currently holds a Q2 ranking in multiple categories including Infectious Diseases and Pulmonary and Respiratory Medicine, reflecting its influence in the academic community. The journal is dedicated to serving researchers, healthcare professionals, and students by offering access to essential information that can improve patient outcomes and enhance public health strategies. As the field of mycobacterial diseases continues to evolve, Journal of Clinical Tuberculosis and Other Mycobacterial Diseases remains a crucial resource for those seeking to remain at the forefront of research and clinical practice.

Parasites & Vectors is a leading open access journal dedicated to the dissemination of high-quality research on the vectors of infectious diseases and their parasitic agents. Published by BMC in the United Kingdom, this journal has been at the forefront of its field since its establishment in 2008, contributing to our understanding of vector-borne pathogens through its rigorous peer-reviewed articles. With a notable impact factor and categorized in the top quartile (Q1) in both Infectious Diseases and Parasitology, it is an essential resource for researchers, professionals, and students worldwide. The journal ranks impressively within various categories, holding a position of 7th out of 194 in Veterinary General Veterinary and 12th out of 79 in Immunology and Microbiology Parasitology, indicating its significant contribution to the sciences. Accessible to all, Parasites & Vectors supports the global pursuit of knowledge in epidemiology and disease control, making it an indispensable platform for sharing innovative findings and fostering collaboration within the scientific community.

Asian Pacific Journal of Tropical Medicine, published by Wolters Kluwer Medknow Publications, stands at the forefront of research in the field of tropical medicine, contributing significantly to the global understanding of health issues prevalent in the Asian Pacific region. With an ISSN of 1995-7645 and an E-ISSN of 2352-4146, this esteemed journal has been an Open Access platform since 2011, ensuring that vital research is accessible to a broad audience. The journal boasts a commendable Scopus rank of 131 out of 636 in the General Medicine category, placing it in the 79th percentile and recognizing its influential contributions to the discipline. Based in Mumbai, India, the journal spans converged years from 2010 to 2024 and is categorized in the Q3 quartile for miscellaneous medicine as of 2023. Researchers, professionals, and students can leverage this journal to stay abreast of the latest findings and developments in tropical medicine, making it an indispensable resource in their academic and professional pursuits.

IJID Regions is a pioneering open access journal published by Elsevier, focusing on the critical fields of epidemiology, infectious diseases, and public health. Established in 2021, the journal aims to provide a platform for disseminating high-quality, innovative research that addresses pressing health issues and informs evidence-based practices in communities around the globe. With its impact factors reflecting a Tier Q2 and Q3 ranking in various medical subcategories on the Scopus platform, IJID Regions is positioned as a valuable resource for researchers, health professionals, and policy-makers striving to enhance public health outcomes. This journal not only champions open access since its inception, promoting the free flow of information, but also welcomes contributions that shed light on contemporary challenges in environmental and occupational health. Its commitment to fostering dialogue and collaboration in the health sciences is paramount, making it an essential read for those engaged in advancing public health knowledge and initiatives.

EPIDEMIOLOGY AND INFECTION is a premier open-access journal published by Cambridge University Press, dedicated to advancing the field of epidemiology and infectious diseases. With an ISSN of 0950-2688 and E-ISSN of 1469-4409, this journal has been at the forefront of disseminating impactful research since its inception in 1970. As of 2023, it holds a prestigious Q2 ranking in both the fields of Epidemiology and Infectious Diseases, reflecting its significant contribution to these critical areas of study, with Scopus rankings placing it at #70 in Epidemiology and #163 in Infectious Diseases. The journal aims to publish high-quality, peer-reviewed studies that contribute to our understanding and management of infectious diseases globally. Operating under an open-access model since 2020, EPIDEMIOLOGY AND INFECTION ensures that research is accessible to a wide audience, fostering collaboration and innovation among researchers, professionals, and students alike. With a commitment to excellence, this journal is an essential resource for those looking to stay abreast of the latest developments in epidemiological research and infectious disease management.

Tropical Medicine and Health is a prestigious open-access journal published by BMC that serves as a vital platform for researchers and health professionals focusing on the fields of tropical medicine, infectious diseases, and public health. With an ISSN of 1348-8945 and an E-ISSN of 1349-4147, the journal has established itself in the academic community since its inception in 2004, bridging the gap between research and real-world applications in managing tropical diseases. Recognized for its quality, it holds a commendable Q2 ranking in both the Infectious Diseases and Public Health, Environmental and Occupational Health categories, positioned in the 2023 Scopus rankings within the 85th and 74th percentiles, respectively. Researchers can access high-quality, peer-reviewed articles that contribute significantly to advancing knowledge in the field. With a commitment to fostering open scientific dialogue, Tropical Medicine and Health is not just a journal, but a collaborative space for researchers, students, and practitioners working to improve health outcomes in tropical regions worldwide.

Open Forum Infectious Diseases (ISSN: 2328-8957; E-ISSN: 2328-8957) is a leading open-access journal published by Oxford University Press, dedicated to advancing the field of infectious diseases. Since its inception in 2014, the journal has provided a platform for researchers to disseminate impactful findings in a rapidly evolving domain, achieving a remarkable Q1 ranking in both the Infectious Diseases and Oncology categories as of 2023. The journal encourages rigorous and innovative research, contributing significantly to global health discussions and informing best practices in clinical settings. As an open-access journal, it ensures that its content is accessible to a wide audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. Positioned in the heart of the United States, Open Forum Infectious Diseases serves as a critical resource for the academic community, and its continued commitment to quality and relevance secures its status as an essential publication in the field.